Abstract
Background
Implantation of foreign materials into mice and humans has been noted to result in the appearance of soft tissue sarcomas at the site of implantation. These materials include metal replacement joints and Dacron vascular grafts. In addition, occupational exposure to nickel has been shown to result in an increased risk of carcinogenesis. The molecular mechanisms of foreign body-induced carcinogenesis are not fully understood. Materials and Methods: In order to gain insight into these mechanisms, we implanted nickel sulfide into wild type C57BL/6 mice as well as a mouse heterozygous for the tumor suppressor gene, p53. Malignant fibrous histiocytomas arose in all mice, and we have characterized the profile of tumor suppressor genes and signal transduction pathways altered in these cells.
Results
All tumors demonstrated hypermethylation of the tumor suppressor gene p16, as well as activation of the mitogen activated protein kinase (MAP kinase) signaling pathway. This knowledge may be beneficial in the prevention and treatment of tumors caused by foreign body implantation.
Conclusions
Oxidative stress induced by nickel sulfide appears to cause loss of p16 and activation of MAP kinase signaling. These findings support the hypothesis of synergistic interactions between MAP kinase activation and p16 loss in carcinogenesis.
Similar content being viewed by others
References
Lotem J, Peled-Kamar M, Groner Y, Sachs L. (1996) Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc. Natl. Acad. Sci. USA 93: 9166–9171.
Driscoll KE, Carter JM, Howard BW, et al. (1998) Crocidolite activates NF-kappa B and MIP-2 gene expression in rat alveolar epithelial cells. Role of mitochrondrial-derived oxidants. Environ. Health Perspect.106Suppl 5: 1171–1174.
Meyskens FL, Jr, Buckmeier JA, McNulty SE, Tohidian NB. (1999) Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin. Cancer Res. 5: 1197–1202.
Tanaka T, Iwasa Y, Kondo S, et al. (1999) High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 18: 3793–3797.
Costa M, Mollenhauer HH. (1980) Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture. Cancer Res. 40: 2688–2694.
Costa M. (1991) Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 31: 321–337.
Klein CB, Costa M. (1997) DNA methylation, heterochromatin and epigenetic carcinogens. Mutat. Res. 386: 163–180.
Nackerdien Z, Kasprzak KS, Rao G, et al. (1991) Nickel(II)—and cobalt(II)–dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 51: 5837–5842.
Abbracchio MP, Heck JD, Costa M. (1982). The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge. Carcinogenesis 3: 175–180.
Costa M, Abbracchio MP, Simmons-Hansen J. (1981) Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. Toxicol. Appl. Pharmacol. 60: 313–323.
Abbracchio MP, Simmons-Hansen J, Costa M. (1982) Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel. J. Toxicol. Environ. Health 9: 663–676.
Reger RB, Morgan WK. (1993) Respiratory cancers in mining. Occup. Med. 8: 185–204.
Tveito G, Hansteen IL, Dalen H, Haugen A. (1989) Immortalization of normal human kidney epithelial cells by nickel(II). Cancer Res. 49: 1829–1835.
Broday L, Peng W, Kuo MH, et al. (2000) Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res. 60: 238–241.
Salnikow K, Blagosklonny MV, Ryan H, et al. (2000) Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60: 38–41.
Salnikow K, Kluz T, Costa M. (1999) Role of Ca(2 +) in the regulation of nickel-inducible Cap43 gene expression. Toxicol. Appl. Pharmacol. 160: 127–132.
Arbiser JL, Raab G, Rohan RM, et al. (1999) Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am. J. Pathol. 155: 723–729.
Arbiser JL, Moses MA, Fernandez CA, et al. (1997) Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA 94: 861–866.
Gressani KM, Rollins LA, Leone-Kabler S, et al. (1998) Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis 19: 1045–1052.
Gressani KM, Leone-Kabler S, O’Sullivan MG, et al. (1999) Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis 20: 2159–2165.
Rollins LA, Leone-Kabler S, O’Sullivan MG, Miller MS. (1998) Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol. Carcinog. 21: 177–184.
Zakut-Houri R, Oren M, Bienz B, et al. (1983) A single gene and a pseudogene for the cellular tumour antigen p53. Nature 306: 594–597.
Hegi ME, Soderkvist P, Foley JF. (1993) Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice m[see comments]. Carcinogenesis 14: 803–810.
Herman JG, Graff JR, Myohanen S, et al. (1996) Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93: 9821–9826.
Swafford DS, Middleton SK, Palmisano WA, et al. (1997) Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol. Cell Biol. 17: 1366–1374.
Arbiser JL, Weiss SW, Arbiser ZK, et al. (2001) Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: Implications for biologic behavior and response to therapy. J. Am. Acad. Dermatol. 44: 1–5.
Evans RM, Davies PJ, Costa M. (1982) Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. Cancer Res. 42: 2729–2735.
Bencko V. (1983) Nickel: a review of its occupational and environmental toxicology. J. Hyg. Epidemiol. Microbiol. Immunol. 27: 237–247.
Huang X, Zhuang Z, Frenkel K. (1994) The role of nickel and nickel-mediated reactive oxygen species in the mechanism of nickel carcinogenesis. Environ. Health Perspect. 102 Suppl 3: 281–284.
Heinemann DE, Lohmann C, Siggelkow H. (2000) Human osteoblast-like cells phagocytose metal particles and express the macrophage marker CD68 in vitro. J. Bone Joint Surg. Br. 82: 283–289.
Ben Izhak O, Vlodavsky E, Ofer A, et al. (1999) Epithelioid angiosarcoma associated with a Dacron vascular graft. Am. J. Surg. Pathol. 23: 1418–1422.
Kirkpatrick CJ, Alves A, Kohler H, et al. (2000) Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am. J. Pathol. 156: 1455–1467.
Liang R, Senturker S, Shi X, et al. (1999) Effects of Ni(II) and Cu(II) on DNA interaction with the N-terminal sequence of human protamine P2: enhancement of binding and mediation of oxidative DNA strand scission and base damage. Carcino-genesis 20: 893–898.
Salnikow K, Gao M, Voitkun V, et al. (1994) Altered oxidative stress responses in nickel-resistant mammalian cells. Cancer Res. 54: 6407–6412.
Zaman K, Ryu H, Hall D, et al. (1999) Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19: 9821–9830.
Salnikow K, Wang S, Costa M. (1997) Induction of activating transcription factor 1 by nickel and its role as a negative regulator of thrombospondin I gene expression. Cancer Res. 57: 5060–5066.
Zatterale A, Kelly FJ, Korkina LG, et al. (1999) Oxidative stress in cancer prone genetic diseases: a review. Ann. Ist. Super. Sanita 35: 205–209.
Bartsch H, Ohshima H, Pignatelli B, Calmels S. (1992) Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 2: 272–277.
Mansour SJ, Matten WT, Hermann AS, et al. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–970.
Cowley S, Paterson H, Kemp P, Marshall CJ. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841–852.
Linardopoulos S, Street AJ, Quelle DE, et al. (1995) Deletion and altered regulation of p16Ink4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res. 55: 5168–5172.
Hussussian CJ, Struewing JP, Goldstein AM, et al. (1994) Germline p16 mutations in familial melanoma. Nat. Genet. 8: 15–21.
Moskaluk CA, Hruban RH, Kern SE. (1997) p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 57: 2140–2143.
Cody DT, Huang Y, Darby CJ, et al. (1999) Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes. Oral Oncol. 35: 516–522.
Wong AK, Chin L. (2000) An inducible melanoma model implicates a role for RAS in tumor maintenance and angiogenesis. Cancer Metastasis Rev. 19: 121–129.
Klafter R, Arbiser JL. (2000) Regulation of angiogenesis and tumorigenesis by signal transduction cascades: lessons from benign and malignant endothelial tumors. J. Investig. Dermatol. Symp. Proc. 5: 79–82.
Tsao H, Zhang X, Fowlkes K, Haluska FG. (2000) Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res. 60: 1800–1804.
Acknowledgments
This project was funded by a Dermatology Foundation Dermik Laboratories Research Grant, a grant from the American Skin Association, grants from the National Institutes of Health AR02030 and RO1 AR47901, and NIAMS Emory Skin Disease Research Core Center P30 AR42687 (JLA). We acknowledge Drs. Lynda Chin and Jef French for helpful discussion. This project was supported in part by the National Research Service Award (NRSA), HL07842 (RK) from the National Institutes of Health, National Heart, Lung and Blood Institute, grants RO1 ES06501 and ES08252 (MSM) from the National Institute of Environmental Health Sciences and Cancer Center Support Grant P30 CA12197 from the National Cancer Institute, which provided support for the Wake Forest University Analytical Imaging Core Facility, the DNA Synthesis Core Laboratory, and the DNA Sequencing and Gene Analysis Facility. We thank Ms. Elyse Jung for assistance with the automated sequencing. Presented in part at the American Association for Cancer Research 91st Annual Meeting, San Francisco, 2000.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by J. Folkman.
Rights and permissions
About this article
Cite this article
Govindarajan, B., Klafter, R., Miller, M.S. et al. Reactive Oxygen-induced Carcinogenesis Causes Hypermethylation of p16Ink4a and Activation of MAP Kinase. Mol Med 8, 1–8 (2002). https://doi.org/10.1007/BF03401997
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401997